Kaplan Myron bought CRMD
October 23, 2025 · Form 4 insider transaction
Kaplan Myron bought 25,000 shares of CorMedix Inc. at $11.02 per share, a transaction worth $275.5K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$11.02
Total value
$275.5K
InsiderKaplan Myron
Role—
CompanyCorMedix Inc. (CRMD)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateOctober 23, 2025
Filing dateOctober 27, 2025
Shares owned after201,034
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.01 to $11.03, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.